BioStock: 2021 – a transformative year for Scandion Oncology

The newly released 2020 annual report for Scandion Oncology summarises what was a year of evolution for the company, but also foreshadows big things to come in 2021. BioStock spoke to Scandion Oncology’s CEO Bo Rode Hansen to get his thoughts on the changes happening at Scandion and on what to look forward to from the company in the coming months.

Read the full interview with Bo Rode Hansen at biostock.se:

https://www.biostock.se/en/2021-a-transformative-year-for-scandion-oncology/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se